Clinical Trial Update: Exemestane-RAD001-Metformin [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of exemestane with RAD001 and metformin for breast cancer was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Exemestane (Exemestane)
• RAD001 (everolimus)
• metformin (metformin)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2020-06-19